cosmos
@cacchasm
Exciting update for Novavax: Their COVID-19 vaccine dose has shown the presence of anti–SARS-CoV-2 mucosal IgA in clinical saliva samples. This is significant because it addresses the usual gap in mucosal immunity, where viruses often replicate even in vaccinated individuals.
0 reply
0 recast
0 reaction